Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-18-028487
Filing Date
2018-09-13
Accepted
2018-09-13 10:36:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 34301
2 filename2.txt TEXT-EXTRACT 4272
  Complete submission text file 0000000000-18-028487.txt   52174
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filed for) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations